ibuprofen has been researched along with Respiratory Distress Syndrome, Newborn in 19 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Respiratory Distress Syndrome, Newborn: A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ibuprofen therapy on the third day of life is as efficacious as indomethacin for the treatment of patent ductus arteriosus in preterm infants with the respiratory distress syndrome and is significantly less likely to induce oliguria." | 5.09 | A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. ( Degroote, K; Langhendries, JP; Lecoutere, D; Smets, K; Van de Broek, H; Van Overmeire, B; Weyler, J, 2000) |
| "Ibuprofen was administered on days 3, 4, and 5 by a 15-minute intravenous infusion of 10, 5, and 5 mg/kg, respectively, with the aim of closing the ductus arteriosus." | 2.70 | Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. ( Kearns, GL; Schepens, PJ; Touw, D; van den Anker, JN; Van Overmeire, B, 2001) |
| "Ibuprofen was not associated with adverse effects." | 2.69 | Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. ( Bertini, G; Dani, C; Fabris, C; Murru, P; Reali, MF; Rubaltelli, FF; Vangi, V, 2000) |
| "Ibuprofen treatment seems to be as efficient as indomethacin in closing PDA on the third day of life in preterm infants with respiratory distress syndrome and seems to have fewer renal side effects." | 2.68 | Treatment of patent ductus arteriosus with ibuprofen. ( Creten, WL; Follens, I; Hartmann, S; Van Acker, KJ; Van Overmeire, B, 1997) |
| "Lower GA (P<0." | 1.35 | Factors affecting postnatal changes in serum creatinine in preterm infants with gestational age <32 weeks. ( Bonsante, F; Ferdinus, C; Gouyon, JB; Iacobelli, S; Labenne, M, 2009) |
| "Ibuprofen is a nonsteroidal anti-inflammatory agent that induces closure of the patent ductus arteriosus in neonates." | 1.35 | An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. ( Eisinger, MJ; Hirt, D; Langhendries, JP; Marguglio, A; Schepens, P; Treluyer, JM; Urien, S; Van Overmeire, B, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, HC | 1 |
| Durand, DJ | 1 |
| Danielsen, B | 1 |
| Dueñas, GV | 1 |
| Powers, RJ | 1 |
| Lu, D | 1 |
| Liu, Y | 1 |
| Tong, X | 1 |
| Haw, MP | 1 |
| Dani, C | 3 |
| Bertini, G | 2 |
| Corsini, I | 1 |
| Elia, S | 1 |
| Vangi, V | 2 |
| Pratesi, S | 1 |
| Rubaltelli, FF | 2 |
| Iacobelli, S | 1 |
| Bonsante, F | 1 |
| Ferdinus, C | 1 |
| Labenne, M | 1 |
| Gouyon, JB | 1 |
| Yokoi, T | 2 |
| Hiraoka, M | 1 |
| Miyamoto, M | 1 |
| Kobayashi, Y | 1 |
| Nishina, S | 1 |
| Azuma, N | 1 |
| Benitz, WE | 1 |
| Sarici, SU | 1 |
| Dabak, O | 1 |
| Erdinc, K | 1 |
| Okutan, V | 1 |
| Lenk, MK | 1 |
| Poggi, C | 1 |
| Fontanelli, G | 1 |
| Heo, MJ | 1 |
| Lee, OS | 1 |
| Lim, SC | 1 |
| Bray, M | 1 |
| Stucchi, I | 1 |
| Fumagalli, M | 1 |
| Pugni, L | 1 |
| Ramenghi, L | 1 |
| Agosti, M | 1 |
| Mosca, F | 1 |
| Heyman, E | 1 |
| Morag, I | 1 |
| Batash, D | 1 |
| Keidar, R | 1 |
| Baram, S | 1 |
| Berkovitch, M | 1 |
| Su, PH | 1 |
| Chen, JY | 1 |
| Su, CM | 1 |
| Huang, TC | 1 |
| Lee, HS | 1 |
| Distefano, G | 1 |
| Hirt, D | 1 |
| Van Overmeire, B | 4 |
| Treluyer, JM | 1 |
| Langhendries, JP | 2 |
| Marguglio, A | 1 |
| Eisinger, MJ | 1 |
| Schepens, P | 1 |
| Urien, S | 1 |
| Follens, I | 1 |
| Hartmann, S | 1 |
| Creten, WL | 1 |
| Van Acker, KJ | 1 |
| Smets, K | 1 |
| Lecoutere, D | 1 |
| Van de Broek, H | 1 |
| Weyler, J | 1 |
| Degroote, K | 1 |
| Reali, MF | 1 |
| Murru, P | 1 |
| Fabris, C | 1 |
| Touw, D | 1 |
| Schepens, PJ | 1 |
| Kearns, GL | 1 |
| van den Anker, JN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus in Premature Infants: A Pilot Study[NCT03103022] | Phase 1 | 20 participants (Actual) | Interventional | 2017-06-12 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for ibuprofen and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Surgical Intervention in Preterm Neonates with Patent Ductus Arteriosus.
Topics: Bronchopulmonary Dysplasia; Combined Modality Therapy; Cyclooxygenase Inhibitors; Ductus Arteriosus, | 2016 |
Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiac Surgical Procedures; Confidence Intervals; Ductus A | 2010 |
[The pharmacological manipulation of Botallo's duct in the duct-dependent congenital cardiopathies and in the preterm infants with respiratory distress. A review and personal findings].
Topics: Alprostadil; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Agents; Cerebral Angiography; C | 2005 |
5 trials available for ibuprofen and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Ductus Arteriosus, Patent; Femal | 2003 |
Treatment of patent ductus arteriosus with ibuprofen.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Administration Schedule; Ductus Arteriosus, Patent; Ec | 1997 |
A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
Topics: Cyclooxygenase Inhibitors; Ductus Arteriosus, Patent; Humans; Ibuprofen; Indomethacin; Infant, Newbo | 2000 |
Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants.
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Apgar Score; Birth Weight; Cyclooxygenase Inhi | 2000 |
Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Ductus Arteriosus; Gestational Age; Human | 2001 |
11 other studies available for ibuprofen and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Hospital variation in medical and surgical treatment of patent ductus arteriosus.
Topics: Birth Weight; California; Cyclooxygenase Inhibitors; Ductus Arteriosus, Patent; Female; Gestational | 2015 |
[Clinical characteristics and cardiac hemodynamic changes of patent ductus ateriosus in preterm infants].
Topics: Birth Weight; Bronchopulmonary Dysplasia; Cardiac Output; Cyclooxygenase Inhibitors; Ductus Arterios | 2015 |
The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance.
Topics: Blood Coagulation; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Resistance; Duc | 2008 |
Factors affecting postnatal changes in serum creatinine in preterm infants with gestational age <32 weeks.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Ductus Arteriosus, Patent; Female; Gestational | 2009 |
Vascular abnormalities in aggressive posterior retinopathy of prematurity detected by fluorescein angiography.
Topics: Capillary Permeability; Ductus Arteriosus, Patent; Female; Fluorescein Angiography; Gestational Age; | 2009 |
An unreported complication of intravenously administered ibuprofen: gastrointestinal bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Ductus Arteriosus, Patent; Gastrointestinal Hemorrhage; Hum | 2012 |
Relationship between platelet count and volume and spontaneous and pharmacological closure of ductus arteriosus in preterm infants.
Topics: Blood Platelets; Cell Size; Cohort Studies; Cyclooxygenase Inhibitors; Ductus Arteriosus, Patent; Fe | 2013 |
Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Comorbidity; Ductus Arteriosus, Paten | 2012 |
Blood withdrawal and infusion via umbilical catheters: effect on cerebral perfusion and influence of ibuprofen.
Topics: Arteries; Blood Pressure; Blood Specimen Collection; Blood Transfusion; Blood Volume; Catheterizatio | 2003 |
Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.
Topics: Administration, Oral; Cerebral Hemorrhage; Drug Evaluation; Ductus Arteriosus, Patent; Gestational A | 2003 |
An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Ductus Arteriosus, Patent; Humans; Ibupro | 2008 |